Central Venous Catheter Use Remains Common at Hemodialysis Initiation Despite Guideline Recommendations
核心洞察
Despite guidelines recommending arteriovenous fistula or graft placement, many patients with kidney failure (搜索) still initiate hemodialysis using a central venous catheter (CVC).
CVCs are easy to place but carry frequent dysfunction and elevated risks for bacteremia (搜索) and endocarditis (搜索) compared with arteriovenous access.
National quality metrics and dialysis unit reimbursement cuts are tied to excessive CVC use, underscoring the clinical and financial stakes of vascular access selection.
Despite clinical guidelines recommending placement of an arteriovenous fistula or graft, many patients with kidney failure (搜索) continue to start hemodialysis with a central venous catheter (CVC), according to a recent analysis of vascular access trends in the United States. The study, reported by NEJM Clinician, examined recent patterns in vascular access methods across all U.S. patients—more than 500,000 individuals—initiating hemodialysis for kidney failure.
The findings highlight a persistent gap between guideline recommendations and real-world clinical practice. Although arteriovenous fistulas and grafts are the preferred forms of vascular access, CVCs remain widely used at the time of dialysis initiation.
Clinical Risks Associated with Central Venous Catheters
The source materials emphasize that CVCs, while easy to place, are associated with meaningful clinical downsides. Specifically, CVCs are linked to frequent dysfunction and higher risks for bacteremia (搜索) and endocarditis (搜索) compared with arteriovenous access. These complications carry significant implications for patient outcomes, as bloodstream infections and cardiac involvement can substantially increase morbidity in a population already burdened by kidney failure (搜索).
Quality Metrics and Reimbursement Implications
Beyond the clinical risks, excessive use of CVCs carries financial and regulatory consequences. National quality metrics and dialysis unit reimbursement cuts are tied directly to excessive CVC use. This linkage means that vascular access selection has implications not only for individual patient safety but also for the operational and financial performance of dialysis facilities, creating an added incentive for providers to reduce reliance on CVCs in favor of arteriovenous fistula or graft placement.
Scope of the Analysis
The analysis draws on a comprehensive national dataset encompassing all U.S. patients initiating hemodialysis for kidney failure (搜索), a population exceeding 500,000 individuals. By examining recent trends in vascular access methods at this scale, the researchers sought to characterize how access practices have evolved over time and to what extent they align with established guidelines favoring arteriovenous fistula or graft placement.